EHOC

Registration & Accommodation

Programs




Leukemia Research

Committees

General Information

Hematology Program 18 October 2018

Poster NO Name Surname Abstract Title
PP-01 MIRELDAR BABAYEV SUCCESSES IN THE FIELD OF CHILD'S LEUKOSOLOGY IN AZERBAIJAN
PP-02 ALINA ANTIPOVA A RARE TYPE OF MIXED PHENOTYPE ACUTE LEUKEMIA T/B-LYMPHOID/MEGAKARYOBLASTIC
PP-03 MAHMUD MAHMUDOV THE STUDY OF QUALITY OF LIFE IN VARIOUS VARIANTS OF ACUTE LEUKEMIA PATIENTS
PP-04 SHAD AHMED HERITBLE RUNX1 AND GATA2 MUTATION WITH A VERY RARE GENE VARIANT ASSOCIATED WITH AML-MDS: A CASE REPORT AND REVIEW OF LITERATURE
PP-05 RAFİYE ÇİFTÇİLER SAFETY AND EFFICACY OF DIFFERENT ARA-C REGIMENS DURING THE CLINICAL COURSE OF ACUTE MYELOID LEUKEMIA
PP-06 MOUSSAB DAMLAJ ROLE OF ALLOGENEIC HCT AS POST REMISSION THERAPY FOR ADULT LYMPHOBLASTIC LEUKEMIA / LYMPHOMA FOLLOWING FRONT LINE HYPERCVAD
PP-07 PINAR CÖMERT A RARE PRESENTATION OF RECURRENCE IN ACUTE LYMPHOBLASTIC LEUKEMIA: ISOLATED OPTIC NERVE INVOLVEMENT
PP-08 SİNAN DEMİRCİOĞLU MUCORMYCOSIS IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT
PP-09 ESRA TERZI DEMIRSOY A RARE ENTITY:PHILADELPHIA-POSITIVE ACUTE MYELOBLASTIC LEUKEMIA WITH P190 FUSION PROTEIN
PP-10 GHADA ELGOHARY MOLECULAR PROFILE OF HEMOGLOBINOPATHY MUTATIONS IN KING KHALID UNIVERSITY HOSPITAL: A SINGLE CENTER EXPERIENCE
PP-11 NASER SHAGERDI ESMAELI IRON DEFICIENCY AND IT’S LEVEL IN IRANIAN PREGNANT WOMEN
PP-12 MÜRÜVVET SEDA AYDIN IS HEREDITARY STOMATOCYTOSIS A RARE ERYTHROCYTE MEMBRANE DISORDER OR AN OVERLOOKED ITEM?
PP-13 ANIL TOMBAK IS L-GLUTAMINE REALLY EFFECTIVE IN REDUCING PAINFULL CRISIS AND HOSPITALIZATION FOR SICKLE CELL ANEMIA PATIENTS IN REAL LIFE?
PP-14 PINAR CÖMERT INTERMITTENT BEVACIZUMAB THERAPY EXPERIENCE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
PP-15 ÖMER EKİNCİ COMPLEMENT-MEDIATED HEMOLYTIC UREMIC SYNDROME: A CASE REPORT
PP-16 ÖMER EKİNCİ CLINICAL FEATURES AND RESPONSES TO ECULIZUMAB OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS: A SINGLE-CENTER EXPERIENCE
PP-17 MEMDUH ŞAHİN EVALUATION OF THE EFFECTS OF IRON DEFICIENCY ANEMIC TREATMENT IN BLOOD LIPID LEVELS AND BODY MEASUREMENTS IN MIDDLE AGE AND ADELOSAN WOMEN
PP-18 MONA ALFARAJ HUMAN PARVOVIRUS B19 AND BLOOD PRODUCT SAFETY: CURRENT AND FURTHER PERSPECTIVES.
PP-19 ENGİN KELKİTLİ EVALUATION OF AUTOIMMUNE HEMOLYTIC ANEMIA PATIENTS AFTER SPLENECTOMY SINGLE CENTRE EXPERIENCE
PP-20 RABBİA LATİF SPECTRUM OF BANE MARROW CHANGES IN ADVANCE STAGE CHRONIC KIDNEY DISEASE
PP-21 SALİH DURUSOY LATE DIAGNOSIS IN SYRIAN IMMIGRANT PATIENT; THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME
PP-22 MERAL ILGAZ ERGIN AUTOLOGOUS STEM CELL TRANSPLANTATION AND CMV
PP-23 RAFİYE ÇİFTÇİLER EXTRAMEDULLARY RELAPSE OF THE AML FOLLOWİNG ALLO-HSCT: A CASE REPORT
PP-24 NASER ESMAELI EVALUATION OF HEMOGLOBIN LEVELS WITH CLINICAL OUTCOME IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
PP-25 MONA HASSANEIN A CASE OF APLASTIC ANEMIA WITH GRAFT FAILURE AND AUTOLOGOUS RECOVERY POST ALLOGENIC STEM CELL TRANSPLANT
PP-26 PINAR CÖMERT AN UNEXPECTED COMPLICATION: TRANSVERSE MYELITIS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION
PP-27 EREN ARSLAN DAVULCU ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT APLASTIC ANEMIA PATIENTS
PP-28 ALİ ÜNAL THE COMPARISON OF MELPHALAN ADMINISTRATION ON DAY–3 WITH ADMINISTRATION ON DAY –1 ON NEUTROPHIL AND PLATELET ENGRAFTMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
PP-29 HACER BERNA AFACAN ÖZTÜRK CD81 EXPRESSION IN THE DIFFERENTIAL DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA
PP-30 AYSUN SENTURK YIKILMAZ ASSOCIATION OF INITIAL PROGNOSTIC PARAMETERS AND REQUIREMENT FOR TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
PP-31 DAMİRA BAYZAKOVA THE ROLE OF NEW TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA IN KYRGYZSTAN
PP-32 ALİ DOĞAN A CASE OF MYASTHENIA GRAVIS DEVELOPING FROM CHRONIC MYELOID LEUKEMIA WITH IMATINIB USE: A CASE REPORT
PP-33 RAFİYE ÇİFTÇİLER A CASE OF IDIOPATHIC HYPEREOSINOPHILIC SYNDROME WITH HEPATIC INVOLVEMENT